Advertisement

Topics

sterna biologicals GmbH & Co. KG Company Profile

17:32 EST 19th January 2019 | BioPortfolio


News Articles [181 Associated News Articles listed on BioPortfolio]

STERNA BIOLOGICALS TO ATTEND BIO-EUROPE(R) 2018 24th ANNUAL INTERNATIONAL PARTNERING CONFERENCE

DGAP-News: sterna biologicals GmbH & Co. KG / Key word(s): Conference 17.10.2018 / 14:00 The issuer is solely responsible for the content of this announcement. STERNA BIOLOGICALS TO ATTEND ...

Health care in Iraq saves money by incorporating off-patent biologicals

Iraq is one of many countries determined to increase its budget savings by replacing appropriate originator biologicals with off-patent biologicals. This is due to the recognition of the proven impact...

Successful device feasibility study with sterna biological's asthma drug candidate SB010 enable selection of optimal nebulizers for late-stage development and commercialization

DGAP-News: sterna biologicals GmbH & Co. KG / Key word(s): Study results 05.09.2018 / 14:00 The issuer is solely responsible for the content of this announcement. Successful device feasibil...

Sterna biologicals prepares for phase IIb clinical program with GATA-3 antagonist drug candidates SB010 in asthma and SB012 in ulcerative colitis

DGAP-News: sterna biologicals GmbH & Co. KG / Key word(s): Miscellaneous 07.01.2019 / 15:00 The issuer is solely responsible for the content of this announcement. STERNA BIOLOGICALS PREPARE...

FDA issues guidance for labelling biologicals and biosimilars

The US Food and Drug Administration (FDA) has issued two new guidance documents that provide recommendations to industry on labelling requirements for biologicals and biosimilars.

Precision BioLogic Acquires Affinity Biologicals

NewsPrecision BioLogic Inc. has completed the acquisition of Affinity Biologicals Inc., a manufacturer of reagents and kits used in hemostasis and thrombosis research and diagnostics.

Positive results for Chinese rituximab and trastuzumab copy biologicals

Researchers from Shanghai Henlius Biotech have presented positive phase III study results for their rituximab [1] and trastuzumab [2] copy biologicals.

Originator biologicals and biosimilars under attack in UK and Japan

Originator biologicals makers and biosimilars makers are finding themselves facing litigation in both the UK and Japan.

Drugs and Medications [80 Associated Drugs and Medications listed on BioPortfolio]

Alcohol prep pad [Büttner-Frank GmbH]

La prairie switzerland [Juvena Produits de Beaute GMBH]

Package.Label Principle Display Panel

Tobramycin [Holopack Verpackungstechnik GmbH]

Tobramycin Inhalation Solution (300 mg/5 mL)

Lonhala [Holopack Verpackungstechnik GmbH]

Glycopyrrolate Inhalation Solution (25 µg/mL)

Purax pure pads [Purax International GmbH]

PURAX Pure Pads Anti-Perspirant Spray

PubMed Articles [37 Associated PubMed Articles listed on BioPortfolio]

Post-marketing dosing changes in the label of biologicals.

To evaluate post-marketing label changes in dosing information of biologicals.

The analgesic potential of cytokine neutralization with biologicals.

Many acute and chronic inflammatory diseases, cancer and neuropathic disorders are accompanied by severe pain states reducing drastically the life quality of the patients. Biologicals which preferenti...

A large single hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents.

Large-scale studies of Drug Provocation Testing (DPT) or Rapid Drug Desensitization (RDD) for hypersensitivity to antineoplastics and biologicals are scarce and limited to a few institutions OBJECTIVE...

Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies.

Biologicals targeting the interleukin (IL)-1β or IL-6 pathway are becoming prime choices for the treatment of children with systemic juvenile idiopathic arthritis (sJIA). Up to 1 in 3 sJIA children r...

A comparison of different farrowing systems - Part 1: Effects on the activity of the sow.

The aim of this study was to determine whether a 3-axis accelerometer (MSR 145B V5.106, MSR Electronics GmbH, Seuzach, Switzerland) can continuously record and display the activity behaviour of sows o...

Clinical Trials [324 Associated Clinical Trials listed on BioPortfolio]

Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib

The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demons...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

The purpose of this Phase II study is to evaluate the feasibility of GSK Biologicals' GSK2197870A vaccine co-administered with Wyeth-Lederle's Prevenar™ when given in healthy infants as ...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

Companies [583 Associated Companies listed on BioPortfolio]

sterna biologicals GmbH & Co. KG

British Biologicals

British Biologicals is an Indian Nutraceutical company, founded in 1988 by Mr. V S Reddy. British Biologicals is headquartered at Bangalore and is popularly known as 'Th...

Novus Biologicals, Inc

The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological researc...

Novus Biologicals Incorporated

Our mission at Novus Biologicals, Inc. is to supply monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

More Information about "sterna biologicals GmbH & Co. KG" on BioPortfolio

We have published hundreds of sterna biologicals GmbH & Co. KG news stories on BioPortfolio along with dozens of sterna biologicals GmbH & Co. KG Clinical Trials and PubMed Articles about sterna biologicals GmbH & Co. KG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of sterna biologicals GmbH & Co. KG Companies in our database. You can also find out about relevant sterna biologicals GmbH & Co. KG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record